Effect of World Health Organization Labour Care Guide On Reducing Cesarean Section Rates

April 19, 2026 updated by: Salma Nisar, Pak Emirates Military Hospital
After taking informed consent for participation in the study, all selected cases will be divided into two groups by lottery method. In group A, patients will receive care using WHO Labour Care Guide while in group B, patients will be monitored using WHO partograph.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

After approval from ethical review committee, total 174 women presenting in the inpatient Department of Obstetrics & Gynaecology, Pak Emirates Military Hospital, Rawalpindi, fulfilling the inclusion criteria will be selected. Informed consent will be taken from each woman. Age, gestational age, parity, height, weight and BMI will be noted. After taking informed consent for participation in the study, all selected cases will be divided into two groups by lottery method. In group A, patients will receive care using WHO Labour Care Guide while in group B, patients will be monitored using WHO partograph. Cesarean section will be noted in both groups. This all data including demographic data will be recorded on a specially designed proforma

Study Type

Interventional

Enrollment (Estimated)

174

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

All pregnant women in active phase of labour (>5cm cervical dilatation) and gestational age of 37 weeks to 41 completed weeks (as assessed on LMP).

Previous no caesarean section. Age 18-40 years. Both primiparous and multiparous. Both booked and unbooked.

Exclusion Criteria:

Women with chronic hypertension (BP >140/90 mmHg on 2 consecutive occasions). Pregnancy induced Hypertension: women with no history of hypertension (blood pressure >140/90 mmHg on 2 consecutive occasions) and diagnosed in pregnancy.

Gestational Diabetes mellitus: women with no history of diabetes mellitus (FBS >110 mg/dl on 2 consecutive occasions) and diagnosed in pregnancy.

Women who had a caesarean section in the latent phase of labour.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
In group A, patients will receive care using WHO Labour Care Guide.
Other: WHO Labour Care Guide
Labour will be monitored using WHO Labour care guide
Placebo Comparator: Group B
In group B, patients will be monitored using WHO partograph.
Other: Partogram
Labour will be monitored using partogram

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of Cesarean Section
Time Frame: 24 hours
To determine the frequency of caesarean section between World Health Organization Labour Care Guidelines versus partograph monitoring of labour.
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pak Emirates Military Hospital

Investigators

  • Principal Investigator: Salma Nisar, MBBS, FCPS, Pak Emirates Military Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

April 19, 2026

First Submitted That Met QC Criteria

April 19, 2026

First Posted (Actual)

April 24, 2026

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 19, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 21042026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labour

Clinical Trials on WHO Labour Care Guide

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe